Cme Group Inc. financial data

Symbol
CME on Nasdaq
Location
20 S. Wacker Dr., Chicago, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -0.13%
Debt-to-equity 505 % +34.2%
Operating Margin 65 % +2.07%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 70.4B USD +6.18%
Weighted Average Number of Shares Outstanding, Basic 360M shares +0.08%
Weighted Average Number of Shares Outstanding, Diluted 360M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.4B USD +5.84%
Costs and Expenses 2.24B USD +1.99%
Operating Income (Loss) 4.16B USD +8.04%
Nonoperating Income (Expense) 692M USD +14.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.85B USD +8.94%
Income Tax Expense (Benefit) 1.08B USD +10.1%
Earnings Per Share, Basic 10 USD/shares +8.4%
Earnings Per Share, Diluted 10 USD/shares +8.63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.45B USD +5.37%
Marketable Securities, Current 123M USD +9.71%
Accounts Receivable, after Allowance for Credit Loss, Current 643M USD +2.15%
Other Assets, Current 547M USD -12.1%
Assets, Current 153B USD +48.1%
Property, Plant and Equipment, Net 355M USD -8.03%
Operating Lease, Right-of-Use Asset 220M USD -8.98%
Goodwill 10.5B USD +0%
Other Assets, Noncurrent 3.63B USD -1.45%
Assets 187B USD +35.8%
Accounts Payable, Current 74.9M USD -42.3%
Liabilities, Current 150B USD +48.4%
Deferred Income Tax Liabilities, Net 5.22B USD -1.69%
Operating Lease, Liability, Noncurrent 249M USD -19%
Other Liabilities, Noncurrent 726M USD -5.68%
Liabilities 159B USD +45.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 43.4M USD
Retained Earnings (Accumulated Deficit) 5.71B USD -2.43%
Stockholders' Equity Attributable to Parent 28.2B USD -0.09%
Liabilities and Equity 187B USD +35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.12B USD +25.1%
Net Cash Provided by (Used in) Financing Activities 19.2B USD +892%
Net Cash Provided by (Used in) Investing Activities -16M USD +29.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 20.3B USD +624%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 151B USD +48.8%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Deferred Tax Assets, Gross 142M USD +5.34%
Operating Lease, Liability 295M USD -16.7%
Depreciation 26.4M USD -6.38%
Payments to Acquire Property, Plant, and Equipment 14.2M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid 342M USD -17.5%
Property, Plant and Equipment, Gross 1.41B USD +5.06%
Operating Lease, Liability, Current 46.3M USD -1.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 49.7M USD -5.69%
Lessee, Operating Lease, Liability, to be Paid, Year One 57.1M USD -1.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -7.4M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44M USD -12.4%
Deferred Tax Assets, Operating Loss Carryforwards 5.3M USD +55.9%
Preferred Stock, Shares Issued 4.6M shares 0%
Unrecognized Tax Benefits 252M USD -4.73%
Lessee, Operating Lease, Liability, to be Paid, Year Four 33.3M USD -32.3%
Operating Lease, Payments 72.6M USD +18%
Amortization of Intangible Assets 223M USD +0.36%
Deferred Tax Assets, Net of Valuation Allowance 142M USD +5.66%